Bellevue Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30K | Hold |
57
| – | – | 0.01% | 204 |
|
|
2025
Q1 | $36.2K | Hold |
57
| – | – | 0.02% | 183 |
|
|
2024
Q4 | $40.6K | Hold |
57
| – | – | 0.02% | 178 |
|
|
2024
Q3 | $59.9K | Hold |
57
| – | – | 0.03% | 144 |
|
|
2024
Q2 | $59.9K | Hold |
57
| – | – | 0.03% | 134 |
|
|
2024
Q1 | $54.9K | Hold |
57
| – | – | 0.03% | 144 |
|
|
2023
Q4 | $50.1K | Hold |
57
| – | – | 0.04% | 152 |
|
|
2023
Q3 | $46.9K | Hold |
57
| – | – | 0.03% | 147 |
|
|
2023
Q2 | $41K | Hold |
57
| – | – | 0.03% | 162 |
|
|
2023
Q1 | $46.8K | Hold |
57
| – | – | 0.03% | 153 |
|
|
2022
Q4 | $40.7K | Hold |
57
| – | – | 0.03% | 162 |
|
|
2022
Q3 | $41K | Hold |
57
| – | – | 0.03% | 168 |
|
|
2022
Q2 | $34K | Hold |
57
| – | – | 0.02% | 191 |
|
|
2022
Q1 | $40K | Buy |
57
+28
| +97% | +$19.6K | 0.02% | 192 |
|
|
2021
Q4 | $18K | Hold |
29
| – | – | 0.01% | 282 |
|
|
2021
Q3 | $18K | Hold |
29
| – | – | 0.01% | 291 |
|
|
2021
Q2 | $16K | Hold |
29
| – | – | 0.01% | 299 |
|
|
2021
Q1 | $14K | Hold |
29
| – | – | 0.01% | 327 |
|
|
2020
Q4 | $16K | Hold |
29
| – | – | 0.01% | 303 |
|
|
2020
Q3 | $16K | Hold |
29
| – | – | 0.01% | 287 |
|
|
2020
Q2 | $18K | Hold |
29
| – | – | 0.02% | 275 |
|
|
2020
Q1 | $16K | Hold |
29
| – | – | 0.02% | 290 |
|
|
2019
Q4 | $11K | Buy |
+29
| New | +$11K | 0.01% | 305 |
|